Telomir Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Miami, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Telomir Pharmaceuticals, Inc. has filed 146 SEC EDGAR filings since 03 Apr 2023

SEC filing history

Showing 51-75 of 146 matching filings.

Per page
25
Current page
3
3

3 filing

Filing date
03 Oct 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95236

SCHEDULE 13G filing

Filing date
18 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jun 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 May 2025
Reporting date
28 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .